Cas:211934-50-8 Dichloro(methoxy)octadecylsilane manufacturer & supplier

Chemical Name:Dichloro(methoxy)octadecylsilane

CAS.NO:211934-50-8

Synonyms:Silane, dichloromethoxyoctadecyl-;Dichloro(methoxy)octadecylsilane;n-Octadecylmethoxydichlorosilane,tech-95

Molecular Formula:C₁₉H₄₀Cl₂OSi

Molecular Weight:383.512

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:429.6±12.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.454

PSA:9.23000

Exact Mass:382.222534

LogP:12.67

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2987

Packing Group:

Contact us for information like Silane, dichloromethoxyoctadecyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,n-Octadecylmethoxydichlorosilane,tech-95 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,n-Octadecylmethoxydichlorosilane,tech-95 Use and application,Dichloro(methoxy)octadecylsilane technical grade,usp/ep/jp grade.

Related News: Bluebird determined that death was highly unlikely to have been caused by the delivery virus used in both Zynteglo and LentiGlobin. [Pd2((trimethylsilyl)methyl)2(μ-Cl)(μ-dppm)2](1+) manufacturers GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. L-cysteinyl-L-valyl-L-tryptophyl-L-cysteinyl-L-asparaginylglycyl-L-arginyl-L-cysteinylglycyl-L-leucine suppliers Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. ethyl 3-(7-(4-fluorobenzyl)-9-hydroxy-8-oxo-7,8-dihydro-6H-pyrrolo[3,4-g]quinolin-5-yl)benzoate vendor & factory Setting up of these plants will make the country self-reliant to a large extent in respect of these bulk drugs, it noted. ,GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said.